Apixaban Tied to Lower Risk for Recurrent VTE in Dialysis Population
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
Bleeding Disorders
COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden
Cinacalcet Does Not Up Risk for Severe Gastrointestinal Bleeding in Hemodialysis
Study is the largest to explore this potential safety issue to date.
FDA Issues Safety Alert Regarding Use of Hydroxyethyl Starch Products
There are currently 4 FDA-approved hydroxyethyl starch products on the market.
Intensive BP Control After ICH May Be Risky for CKD Patients
Intensive BP lowering after intracerebral hemorrhage linked to poorer outcomes in patients with decreased renal function
- Loading...
Loading...
Next post in Hypertension
Loading... 
Loading...